RECENT PLACEMENT

Occam Places Mary Kay Fenton as CFO at Semma

Occam Places Mary Kay Fenton as CFO at Semma

Semma Therapeutics is a cell therapy company founded by Doug Melton of Harvard University and financed by ARCH Venture, MPM, and F-Prime. The company was subsequently acquired by Vertex for approximately $1B in late 2019.

In May 2019, Occam placed Mary Kay Fenton as CFO, having years of experience working with fast-growing biotech companies, most recently as EVP and CFO of Achillion Pharmaceuticals. With Fenton in place, Semma was subsequently acquired by Vertex for $1B.

‍

Recent Placements

  1. Avirup Bose, Ph.D., as Chief Business Officer of Iktos
  2. Steve Harrison as CSO at Nucleome
  3. Aimee Einstein as VP of People & Culture at SI-BONE
  4. David Brower as CBO for Oncology Biotech Accent Therapeutics
  5. Annette Matthies as CBO at Elicio Therapeutics
  6. Steve Staben as CSO at Lycia Therapeutics
About Occam Global

Occam Global is a leading executive search and advisory partner for entrepreneurs, investors, and corporations targeting exceptional goals across the life sciences, deep tech, and venture capital sectors worldwide.  Since 2012, Occam has collaborated with top founders, CEOs, and investors across the tech industry to provide high-performing leaders who fuel growth. From stealth startups to public markets, we recruit senior executives, advise on organizational strategies, and invest alongside visionary teams to build innovative companies.  Occam’s success is rooted in our proven ability to attract outstanding business and scientific leaders, seamless access to rare talent, and a strong commitment to results guided by high ethics and enlightened aggression.  Whether you’re launching, leading, or investing, we are here to support growth through the power of talent.